Position in DERM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$581,614
+$46,425 QoQ
Shares Held
82,149
+18.3% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 71 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DERM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $1,255,121,114 across 64 Drug Manufacturers - Specialty & Generic names. DERM ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
9,668,611 | $237,944,516 | |
| 2 | ZTS |
Zoetis Inc.
|
3,188,263 | $229,108,578 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
304,692 | $165,091,266 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
1,376,480 | $152,706,691 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,667,827 | $109,460,941 | |
| 6 | ALKS |
Alkermes plc.
|
1,645,101 | $86,203,291 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,373,982 | $63,903,902 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
846,936 | $29,363,271 |
All Filings in DERM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $581,614 | 82,149 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $535,189 | 69,415 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $102,455 | 14,390 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $290,628 | 49,259 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $174,260 | 44,568 | Shares | Defined | 2025-02-14 | |
| 2023-12-31 | $65,416 | 11,357 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $57,894 | 10,761 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||